MediSieve is founded in 2015, operates from its headquarter in 80 Wood Lane London, England W12 0BZ, GB. The company operates in the Hospitals & Healthcare, Medical Practices sector.
MediSieve specializes in Magnetic Haemofiltration technology, Substance removal from bloodstream, Pre-clinical validation, Clinical study preparation, Regulatory approval processes, and offers services including Magnetic Haemofiltration, Direct treatment through substance removal, and Enhanced safety and efficacy of other therapies.